PHARMACOKINETICS/PHARMACODYNAMICS/PHARMACOGENETICS OF DINACICLIB AND DINACICLIB GLUCURONIDE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Zhao, Y. [1 ]
Ling, Y. [1 ]
Poi, M. [1 ]
Schaaf, L. J. [1 ]
Johnson, A. J. [1 ]
Byrd, J. C. [1 ]
Jones, J. A. [1 ]
Phelps, M. A. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2015年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-075
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics of venetoclax in patients with 17p deletion chronic lymphocytic leukemia
    Salem, Ahmed Hamed
    Dunbar, Martin
    Agarwal, Suresh K.
    ANTI-CANCER DRUGS, 2017, 28 (08) : 911 - 914
  • [22] Pharmacogenetics in the treatment of chronic lymphocytic leukemia: what does the future hold?
    Johnson, Gillian G.
    Carr, Daniel F.
    Pirmohamed, Munir
    Pettitt, Andrew R.
    PHARMACOGENOMICS, 2014, 15 (07) : 897 - 900
  • [23] Pharmacokinetics of ibrutinib in a patient with chronic lymphocytic leukemia on hemodialysis
    Ohtani, Toyoji
    Tani, Akiko
    Namme, Yuki
    Namme, Rie
    Hirose, Maki
    Shingu, Ikuo
    Kizawa, Yusuke
    Endo, Akira
    Yasu, Takeo
    CLINICAL NEPHROLOGY, 2022, 98 (06) : 301 - 304
  • [24] Assessing the pharmacokinetics of acalabrutinib in the treatment of chronic lymphocytic leukemia
    Miao, Yi
    Xu, Wei
    Li, Jianyong
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (09) : 1023 - 1030
  • [25] PHARMACOKINETICS AND PHARMACODYNAMICS OF METHADONE IN PATIENTS WITH CHRONIC PAIN
    INTURRISI, CE
    COLBURN, WA
    KAIKO, RF
    HOUDE, RW
    FOLEY, KM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (04) : 392 - 401
  • [26] Update on the Phase I Study of the Cyclin Dependent Kinase Inhibitor Dinaciclib (SCH 727965) In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Confirmation of Clinical Activity and Feasibility of Long-Term Administration.
    Flynn, Joseph M.
    Jones, Jeffrey A.
    Andritsos, Leslie
    Blum, Kristie A.
    Johnson, Amy J.
    Hessler, Josh
    Wiley, Elizabeth
    Poon, Jennifer
    Small, Karen
    Statkevich, Paul
    Grever, Michael R.
    Bannerji, Rajat
    Byrd, John C.
    BLOOD, 2010, 116 (21) : 600 - 601
  • [27] Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia
    Ishida, Yoji
    Murai, Kazunori
    Yamaguchi, Kohei
    Miyagishima, Takuto
    Shindo, Motohiro
    Ogawa, Kazuei
    Nagashima, Takahiro
    Sato, Shinji
    Watanabe, Reiko
    Yamamoto, Satoshi
    Hirose, Takayuki
    Saitou, Souich
    Yonezumi, Masakatsu
    Kondo, Takeshi
    Kato, Yuichi
    Mochizuki, Noboru
    Ohno, Keiko
    Kishino, Satoshi
    Kubo, Kohmei
    Oyake, Tatsuo
    Ito, Shigeki
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (02) : 185 - 193
  • [28] Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia
    Yoji Ishida
    Kazunori Murai
    Kohei Yamaguchi
    Takuto Miyagishima
    Motohiro Shindo
    Kazuei Ogawa
    Takahiro Nagashima
    Shinji Sato
    Reiko Watanabe
    Satoshi Yamamoto
    Takayuki Hirose
    Souich Saitou
    Masakatsu Yonezumi
    Takeshi Kondo
    Yuichi Kato
    Noboru Mochizuki
    Keiko Ohno
    Satoshi Kishino
    Kohmei Kubo
    Tatsuo Oyake
    Shigeki Ito
    European Journal of Clinical Pharmacology, 2016, 72 : 185 - 193
  • [29] The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemia
    Jan de Jong
    Juthamas Sukbuntherng
    Donna Skee
    Joe Murphy
    Susan O’Brien
    John C. Byrd
    Danelle James
    Peter Hellemans
    David J. Loury
    Juhui Jiao
    Vijay Chauhan
    Erik Mannaert
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 907 - 916
  • [30] The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemia
    de Jong, Jan
    Sukbuntherng, Juthamas
    Skee, Donna
    Murphy, Joe
    O'Brien, Susan
    Byrd, John C.
    James, Danelle
    Hellemans, Peter
    Loury, David J.
    Jiao, Juhui
    Chauhan, Vijay
    Mannaert, Erik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (05) : 907 - 916
12345